References
American Society of Health System Pharmacists. (2006). ASHP guidelines on handling hazardous drugs. American Journal of Health-System Pharmacy, 63, 1172-1193. doi:10.2146/ajhp050529
Cooper, M. D., & Phillips, R. A. (2004). Exploratory analysis of the safety climate and safety behavior relationship. Journal of Safety Research, 35, 497-512.
DeJoy, D. M., Gershon, R. R. M., & Schaffer, B. S. (2004, July). Safety climate: Assessing management and organizational influences on safety. Professional Safety, 50-57.
DeJoy, D. M., Murphy, L. R., & Gershon, R. R. M. (1995). The influence of employee, job/task, and organizational factors on adherence to universal precautions among nurses. International Journal of Industrial Ergonomics, 16, 43-55. doi:10.1016/0169-8141(94)00075-E
DeJoy, D. M., Searcy, C. A., Murphy, L. R., & Gershon, R. R. (2000). Behavioral-diagnostic analysis of compliance with universal precautions among nurses. Journal of Occupational Health Psychology, 5, 127-141.
Dillman, D. A. (2007). Mail and Internet surveys: The Tailored Design Method (2nd ed.). Hoboken, NJ: John Wiley and Sons.
Faul, F., Erdfelder, E., Lang, A. G., & Buchner, A. (2007). G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods, 39, 175-191. doi:10.3758/BF03193146
Fransman, W., Roeleveld, N., Peelen, S., de Kort, W., Kromhout, H., & Heederik, D. (2007). Nurses with dermal exposure to antineoplastic drugs: Reproductive outcomes. Epidemiology, 18, 112-119. doi:10.1097/01.ede.0000246827.44093.c1
Friese, C. R., Himes-Ferris, L., Frasier, M. N., McCullagh, M. C., & Griggs, J. J. (2011). Structures and processes of care in ambulatory oncology settings and nurse-reported exposure to chemotherapy. BMJ Quality and Safety. Advance online publication. doi:10.1136/bmjqs-2011-000178
Fuchs, J., Hengstler, J. G., Jung, D., Hiltl, G., Konietzko, J., & Oesch, F. (1995). DNA damage in nurses handling antineoplastic agents. Mutation Research, 342, 17-23. doi:10.1016/0165-1218(95)90086-1
Geer, L. A., Anna, D. H., Curbow, B. A., Diener-West, M., de Joode, B. W., Mitchell, C. S., & Buckley, T. J. (2007). Survey assessment of worker dermal exposure and underlying behavioral determinants. Journal of Occupational and Environmental Hygiene, 4, 809-820. doi:10.1080/15459620701612722
Geer, L. A., Curbow, B. A., Anna, D. H., Lees, P. S. J., & Buckley, T. J. (2006). Development of a questionnaire to assess worker knowledge, attitudes and perceptions underlying dermal exposure. Scandinavian Journal of Work and Environmental Health, 32, 209-218.
Gershon, R. R. M., Karkashian, C. D., Grosch, J. W., Murphy, L. R., Escamilla-Cejudo, A., Flanagan, P. A., … Martin, L. (2000). Hospital safety climate and its relationship with safe work practices and workplace exposure incidents. American Journal of Infection Control, 28, 211-221.
Gershon, R. R. M., Mitchell, C. S., Sherman, M. F., Vlahov, D., Lears, M. K., Felknor, S. A., & Lubelczyk, R. A. (2005). Hepatitis B vaccination in correctional health care workers. American Journal of Infection Control, 33, 510-518. doi:10.1016/j.ajic.2005.04.245
Gershon, R. R. M., Qureshi, K. A., Pogorzelska, B. A., Rosen, J., Gebbie, K. M., Brandt-Rauf, P., & Sherman, M. F. (2007). Non-hospital based registered nurses and the risk of bloodborne pathogen exposure. Industrial Health, 45, 695-704. doi:10.2486/indhealth.45.695
Gershon, R. R. M., Stone, P. W., Bakken, S., & Larson, E. (2004). Measurement of organizational culture and climate in healthcare. Journal of Nursing Administration, 34, 33-40.
Gershon, R. R. M., Vlahov, D., Felknor, S. A., Vesley, D., Johnson, P. C., Delclos, G. L., & Murphy, L. R. (1995). Compliance with universal precautions among health care workers at three regional hospitals. American Journal of Infection Control, 23, 225-236. doi:10.1016/0196-6553(95)90067-5
Grosch, J. W., Gershon, R. R. M., Murphy, L. R., & DeJoy, D. M. (1999). Safety climate dimensions associated with occupational exposure to blood-borne pathogens in nurses. American Journal of Industrial Medicine, 36(Suppl. 1), 122-124. doi:10.1002/(SICI)1097-0274(199909)36:1+<122::AID-AJIM43>3.0.CO;2-L
Hansen, J., & Olsen, J. H. (1994). Cancer morbidity among Danish female pharmacy technicians. Scandinavian Journal of Work and Environmental Health, 20, 22-26.
Harrison, B. R. (2001). Risks of handling cytotoxic drugs. In M. C. Perry (Ed.), The chemotherapy source book (3rd ed., pp. 566-582). Philadelphia, PA: Lippincott, Williams and Wilkins.
Lusk, S. L., Ronis, D. L., & Hogan, M. M. (1997). Test of the health promotion model as a causal model of construction workers' use of hearing protection. Research in Nursing and Health, 20, 183-194.
Mahon, S. M., Casperson, D. S., Yackzan, S., Goodner, S., Hasse, B., Hawkins, J., … Witcher, V. (1994). Safe handling practices of cytotoxic drugs: The results of a chapter survey. Oncology Nursing Forum, 21, 1157-1165.
Martin, S. (2003). Chemotherapy handling and effects among nurses and their offspring (Doctoral dissertation). Columbia University, New York, NY.
Martin, S., & Larson, E. (2003). Chemotherapy-handling practices of outpatient and office-based oncology nurses. Oncology Nursing Forum, 30, 575-581. doi:10.1188/03.ONF.575-581
McCullagh, M., Lusk, S. L., & Ronis, D. L. (2002). Factors influencing use of hearing protection among farmers: A test of the Pender Health Promotion Model. Nursing Research, 51, 33-39. doi:10.1097/00006199-200201000-00006
McDiarmid, M. A., Oliver, M. S., Roth, T. S., Rogers, B., & Escalante, C. (2010). Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. Journal of Occupational and Environmental Medicine, 52, 1028-1034. doi:10.1097/JOM.0b013e3181f73ae6
Moore, D., Gamage, B., Bryce, E., Copes, R., Yassi, A., & BC Interdisciplinary Respiratory Protection Study Group. (2005). Protecting health care workers from SARS and other respiratory pathogens: Organizational and individual factors that affect adherence to infection control guidelines. American Journal of Infection Control, 33(2), 88-96. doi:10.1016/j.ajic.2004.11.003
National Institute for Occupational Safety and Health. (2004). Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. Retrieved from
http://www.cdc.gov/niosh/docs/2004-165
Nieweg, R. M., de Boer, M., Dubbleman, R. C., Gall, H. E., Hesselman, G. M., Lenssen, P. C., … Slegt, J. H. (1994). Safe handling of antineoplastic drugs: Results of a survey. Cancer Nursing, 17, 501-511. doi:10.1097/00002820-199412000-00008
Occupational Safety and Health Administration. (1986). OSHA work-practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. American Journal of Hospital Pharmacy, 43(Appendix 7), 1193-1204.
Pender, N. J., Murdaugh, C., & Parsons, M. A. (Eds.). (2006). Health promotion in nursing practice (5th ed.). Upper Saddle River, NJ: Prentice Hall.
Peterson, S. J., & Bredow, T. S. (Eds.). (2004). Middle-range theories: Application to nursing research. Philadelphia, PA: Lippincott, Williams and Wilkins.
Polit, D. F., Beck, C. T., & Owen, S. V. (2007). Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Research in Nursing and Health, 30, 459-467.
Polovich, M., & Martin, S. (2011). Nurses' use of hazardous drug-handling precautions and awareness of national safety guidelines. Oncology Nursing Forum, 38, 718-726. doi:10.1188/11.ONF.718-726
Polovich, M., Whitford, J. M., & Olsen, M. (Eds.). (2009). Chemotherapy and biotherapy guidelines and recommendations for practice (3rd ed.). Pittsburgh, PA: Oncology Nursing Society.
Skov, T., Maarup, B., Olsen, J., Rorth, M., Winthereik, H., & Lynge, E. (1992). Leukaemia and reproductive outcome among nurses handling antineoplastic drugs. British Journal of Industrial Medicine, 49, 855-861. doi:10.1136/oem.49.12.855
Stajicj, G. V., Barnett, C. W., Turner, S. V., & Henderson, C. A. (1986). Protective measures used by oncologic office nurses handling parenteral antineoplastic agents. Oncology Nursing Forum, 13, 47-49.
Testa, A., Gianchelia, M., Palma, S., Appolloni, M., Padua, L., Tranfo, G., … Cozzi, R. (2007). Occupational exposure to antineoplastic agents induces a high level of chromosome damage. Lack of an effect of GST polymorphisms. Toxicology and Applied Pharmacology, 223, 46-55. doi:10.1016/j.taap.2007.05.006
Valanis, B., McNeil, V., & Driscoll, K. (1991). Staff members' compliance with their facility's antineoplastic drug handling policy. Oncology Nursing Forum, 18, 571-576.
Valanis, B., & Shortridge, L. (1987). Self protective practices of nurses handling antineoplastic drugs. Oncology Nursing Forum, 14(3), 23-27.
Valanis, B., Vollmer, W. M., Labuhn, K., & Glass, A. (1993a). Acute symptoms associated with antineoplastic drug handling among nurses. Cancer Nursing, 16, 288-295. doi:10.1097/00002820-199308000-00005
Valanis, B., Vollmer, W. M., Labuhn, K., & Glass, A. (1993b). Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel. American Journal of Hospital Pharmacy, 50, 455-462.
Valanis, B., Vollmer, W. M., Labuhn, K., & Glass, A. (1997). Occupational exposure to antineoplastic agents and self-reported infertility among nurses and pharmacists. Journal of Occupational and Environmental Medicine, 39, 574-580. doi:10.1097/00043764-199706000-00013
Yoshida, J., Kosaka, H., Tomika, K., & Kumagai, S. (2006). Genotoxic risks to nurses from contamintion of the work environment with antineoplastic drugs in Japan. Journal of Occupational Health, 48, 517-522. doi:10.1539/joh.48.517